Daily The Business

chudaihd busty blonde fucks her pink cunt with her bbc toy. alle de pornos turkish ayse. http://www.kittytube.club

Sancos Cough syrup disappears from markets, reveals survey

 152 drug inspectors collect whole stocks: Chief Drug Controller

 By K A Mian

 LAHORE: The Sancos Syrup of the Novartis Pharma Pakistan Limited (NPPL) was removed immediately from the pharmacies and medical stores across the province on Tuesday in the backdrop of the Drug Regulatory Authority of Pakistan (DRAP)’s directions.   

Through a newspaper public notice a couple of days ago, the company had urged the doctors, pharmacists, retailers, chemists, wholesalers, hospitals, distributors, patients and caregivers to immediately stop selling and using of Sancos Syrup. The mentioned Syrup was manufactured for NPPL by a third party i.e GlaxoSmithKline OTC Pvt. Located at Petaro Road, Jamshoro (ex-Novartis factory).

A survey conducted by Daily The Business in the provincial capital revealed that the Chief Drug Controller Punjab office teams raided the places in all parts of the province to make it sure that the shopkeepers removed the cough syrup. Through the public notice, the company had appealed that to stop using this syrup 120 ml with immediate effect and in case they have any unused or partially used Sancos syrup, return the same to Novartis Head Office.

When contacted by this reporter to know about the enforcements, Chief Drug Controller Punjab Munawar Hayat said after receiving the directions from the DRAP, he passed instructions to all field force of the Drug Control Administration to recall/recover/seal all the stock of the said product, available in the markets of Punjab. He maintained with the help of 152 drug inspectors all stocks have been collected.

Hayat said the syrup manufactured by Ms Novartis is sold across the country and it is commonly prescribed for cough, adding now all rights of its company have been sold to the GlaxoSmithKline (GSK). He said GSK had applied for transfer of the registration (it would be cancelled from Novartis and registered with GSK), after completion of this conversion process its price would be actualised.

Hayat further said the GSK would apply for releasing of specified quota (quantity) to the Control Drug Department. After that GSK would start manufacturing it, then its studies would also be carried out and after six months said syrup would be available in markets. The CDC claimed that the Sancso Syrup isn’t available at any medical stores across the province. In this regard, operations have been completed by field officers. To probe the situation, this correspondent visited some markets and witnessed the absence of syrup.

When contacted, DRAP Additional Director Akhtar Abbas told Daily The Business that it came to his knowledge during a random check in February 2018 that syrup was out of specification, adding that initially, the company claimed that the problem was in just a few batches.  After that, the company requested the DRAP to allow it to reduce shelf life (expiry duration) of the syrup from three years to 18 months. Abbas further said the DRAP directed the company to withdraw the syrup from the market.

The company resisted first the direction but finally, the problem has been settled and it has advertised that the syrup is being recalled, he maintained. He vowed the DRAP had started circulating the letters on the official social media to aware the general public about a sensitive issue.

“According to our information, now syrup is not being sold as medical stores and doctors have also learnt about the issue,” Abbas said. He disclosed that the Drug Control Board meeting is being held today (Wednesday) in which two issues including stability of syrup and transfer of registration will be discussed.

Dr Zeeshan Danish Technical Member/Judge of the Drug Court Punjab said the company has advertised that it has been voluntarily recalling Sancos syrup of all doses from the market to save the precious lives. “It should be appreciated at all as the company adopted the worldwide best practices to recall such products.”

Danish revealed at least six drug courts have been established in Punjab to control the distribution of low-quality medicine.  He mentioned the decision has been taken by the provincial government in line with the commitment to patient’s safety; provide the public with quality control medicines, taking action against unregistered manufacturers and ethical practices.

He concluded that as many as 3,500 cases were disposed of in 2017 of which more than 700 accused were convicted and imprisoned for up to 100 years.

Leave A Reply

Your email address will not be published.

busty perfect blonde rubs clit on webcam.https://pornsocket.cc cumshot ins gesicht schwester.
outstanding beauty fucking and sucking. sexyvideoshd.net mi colita sigue virgen.
freeporn danza hot by blanca gar.